PUBLIC COMPANY
saveKolon TissueGene Inc
updated 4mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Biopharma recruiters see ‘signs of recovery’ as layoffs remain cool in Q3’26A more subdued volume of biopharma layoffs continued into the third quarter of 2026, validating predictions that the sector has moved beyond the avalanche of redundancies experienced last year.fiercebiotech · 5d ago
- Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial missFollowing a phase 3 knee osteoarthritis failure that its CEO acknowledged caused “great disappointment and concern,” Kolon TissueGene is laying off 37 employees at its Maryland headquarters.fiercebiotech · 1mo ago
- Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trialA phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study scheduled to report data in October, the biotech is holding off on…fiercebiotech · 2mo ago
comments(0)
5-min edit window · permanent after that